Ticker Details
Arvinas, Inc.
IPO Date:	September 24, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$586.5M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.00 | 2.91%
Avg Daily Range (30 D):	$0.23 | 2.31%
Avg Daily Range (90 D):	$0.31 | 2.66%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.7M
Avg Daily Volume (90 D):	.69M

Trade Size
Avg Trade Size (Sh.):	72
Avg Trade Size (Sh.) (30 D):	58
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	3,323
Avg Institutional Trade:	$2.16M
Avg Institutional Trade (30 D):	$1.26M
Avg Institutional Trade (90 D):	$1.49M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.53M
Avg Closing Trade (30 D):	$1.26M
Avg Closing Trade (90 D):	$1.53M
Avg Closing Volume:	93.49K

News

May 20, 2026 @ 5:00 PM ESR1-Mutated Metastatic Breast Cancer Market Expec... Source: Delveinsight

May 12, 2026 @ 6:38 PM Rigel Pharmaceuticals Inks Breast Cancer Drug Deal... Source: Vandana Singh

May 5, 2026 @ 11:00 AM Arvinas to Report First Quarter 2026 Financial Res... Source: Na

May 4, 2026 @ 4:30 PM Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind ... Source: Vandana Singh

May 1, 2026 @ 4:43 PM Arvinas Announces FDA Approval of VEPPANU (vepdege... Source: Arvinas, Inc.

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS		$-.9	$-.48
Diluted EPS		$-.9	$-.48
Revenue		$15.6M	$41.9M
Gross Profit
Net Income / Loss		$-57.6M	$-35.1M
Operating Income / Loss		$-63.8M	$-43.8M
Cost of Revenue
Net Cash Flow		$-55.6M	$-13.4M
PE Ratio